Oslo, Norway, 30 April 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, invites to a webcast presentation of its first quarter 2025 results, on Thursday, May 8, 2025.
Zelluna ASA: Invitation to First Quarter 2025 results webcast presentation
Seeking Alpha / 9 minutes ago 3 Views
Comments